LifeMD (LFMDP) Competitors $24.28 +0.36 (+1.48%) As of 11:22 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LFMDP vs. ACONW, AONC, DHACW, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. LifeMD vs. Aclarion American Oncology Network Digital Health Acquisition Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation and community ranking. Is ACONW or LFMDP more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A LifeMD N/A N/A N/A Does the MarketBeat Community believe in ACONW or LFMDP? Aclarion and LifeMD both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/ALifeMDN/AN/A Does the media refer more to ACONW or LFMDP? In the previous week, LifeMD had 3 more articles in the media than Aclarion. MarketBeat recorded 4 mentions for LifeMD and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.87 beat LifeMD's score of 0.37 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive LifeMD Neutral Which has higher valuation & earnings, ACONW or LFMDP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$45.72KN/AN/AN/AN/ALifeMD$212.45MN/AN/AN/AN/A SummaryLifeMD beats Aclarion on 2 of the 3 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMDP vs. The Competition Export to ExcelMetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$206.81M$5.49B$7.97BDividend Yield11.99%6.68%5.11%4.23%P/E RatioN/A220.0022.6118.58Price / SalesN/A436.64397.51103.15Price / CashN/A47.1438.1834.62Price / BookN/A5.236.704.26Net IncomeN/A-$15.55M$3.22B$248.31M7 Day Performance4.22%-0.40%1.26%1.34%1 Month Performance-8.36%-0.60%3.73%3.92%1 Year Performance6.51%5.88%15.82%5.33% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDPLifeMDN/A$24.29+1.5%N/A+8.8%$0.00$212.45M0.00230Upcoming EarningsShort Interest ↑ACONWAclarionN/A$0.04-10.0%N/A-48.0%$0.00$45,724.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$6.45-0.6%N/A+64.9%$0.00$1.34B0.001,520Positive NewsDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/AOTRKPOntrakN/A$0.23+0.0%N/A-45.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-4.7%N/A-80.3%$0.00$1.50B0.00500Gap UpHigh Trading VolumeTALKWTalkspaceN/A$0.12+6.4%N/A-57.1%$0.00$187.59M0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.10-4.3%N/A-69.0%$0.00$393.41M0.00660Short Interest ↓News CoverageNTRANatera2.8621 of 5 stars$152.35-0.4%$175.76+15.4%+62.5%$20.72B$1.70B-87.093,020Upcoming EarningsInsider TradePositive NewsFMSFresenius Medical Care3.8408 of 5 stars$25.02-0.2%$25.30+1.1%+20.6%$14.70B$19.34B20.70123,200Upcoming EarningsPositive NewsHIMSHims & Hers Health2.3721 of 5 stars$34.66+21.7%$36.58+5.5%+164.1%$7.87B$1.48B80.49650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading Volume Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMDP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFMDP Stock Free LFMDP Stock Alerts